KCNJ10 and myeloid sarcoma: Considering prior findings that increased serum Kir4.1 antibody levels are associated with MS patients,[32] we utilized ELISA to detect the expression level of anti‐Kir4.1 antibodies in serum samples obtained from both EAE mice and MS patients (Figure 1B; Table S1, Supporting Information).